WordNet

of or belonging to neither the right nor the left politically or intellectually
a building dedicated to a particular activity; "they were raising money to build a new center for research" (同)centre
(American football) the position of the player on the line of scrimmage who puts the ball in play; "it is a centers responsibility to get the football to the quarterback"
a position on a basketball team of the player who participates in the jump that starts the game
the position on a hockey team of the player who participates in the face off at the beginning of the game
a place where some particular activity is concentrated; "they received messages from several centers" (同)centre
the sweet central portion of a piece of candy that is enclosed in chocolate or some other covering (同)centre
the object upon which interest and attention focuses; "his stories made him the center of the party" (同)centre, center of attention, centre of attention
an area that is approximately central within some larger region; "it is in the center of town"; "they ran forward into the heart of the struggle"; "they were in the eye of the storm" (同)centre, middle, heart, eye
a point equidistant from the ends of a line or the extremities of a figure (同)centre, midpoint
a cluster of nerve cells governing a specific bodily process; "in most people the speech center is in the left hemisphere" (同)centre, nerve_center, nerve centre
(football) the person who plays center on the line of scrimmage and snaps the ball to the quarterback; "the center fumbled the handoff" (同)snapper
(basketball) the person who plays center on a basketball team
(ice hockey) the person who plays center on a hockey team
politically moderate persons; centrists
the middle of a military or naval formation; "they had to reinforce the center"
move into the center; "That vase in the picture is not centered" (同)centre
equally distant from the extremes (同)halfway, middle, midway
relating to or applicable to or concerned with the administration of a city or town or district rather than a larger area; "local taxes"; "local authorities"
public transport consisting of a bus or train that stops at all stations or stops; "the local seemed to take forever to get to New York"
affecting only a restricted part or area of the body; "local anesthesia"
of or belonging to or characteristic of a particular locality or neighborhood; "local customs"; "local schools"; "the local citizens"; "a local point of view"; "local outbreaks of flu"; "a local bus line"
of or relating to infection; "infectious hospital"; "infectious disease"
caused by infection or capable of causing infection; "viruses and other infective agents"; "a carrier remains infective without himself showing signs of the disease" (同)infective
easily spread; "fear is exceedingly infectious; children catch it from their elders"- Bertrand Russell
close observation of a person or group (usually by the police)

PrepTutorEJDIC

『一地方の』,ある土地の,(特に)自分の住んでいる土地の;地方に特有な / (全体からみて)『部分的な』,局部の,狭い部分の / 《米》各駅停車の / 《話》《しばしば複数形で》その土地に住んでいる人々 / 《米話》(新聞の)地方記事 / 《話》(各駅停車の)列車,電車,バス / 《米》(労働組合などの)支部
低カロリーの
(病気が)伝染する,伝染性の / (影響などが)感化しやすい,うつりやすい
(特に容疑者・囚人などの)監視,見張り / 監督,指揮

UpToDate Contents

全文を閲覧するには購読必要です。 To read the full text you will need to subscribe.

1. 末梢神経ブロックの概要 overview of peripheral nerve blocks
2. 先進国に居住する成人の急性下痢へのアプローチ approach to the adult with acute diarrhea in resource rich settings
3. 性器潰瘍患者へのアプローチ approach to the patient with genital ulcers
4. 濾胞性リンパ腫の臨床症状、病理学的特徴、診断、および予後 clinical manifestations pathologic features diagnosis and prognosis of follicular lymphoma
5. 国際養子縁組：感染症の側面 international adoption infectious disease aspects

English Journal

Co-circulation of H5N6, H3N2, H3N8, and Emergence of Novel Reassortant H3N6 in a Local Community in Hunan Province in China.

Li X1, Yang J1, Liu B1, Jia Y1, Guo J1, Gao X1, Weng S1, Yang M1, Wang L1, Wang LF2, Cui J3,2, Chen H4, Zhu Q1.
Scientific reports.Sci Rep.2016 May 6;6:25549. doi: 10.1038/srep25549.
Multiple infections of avian influenza viruses (AIVs) in poultry or wild birds contribute to the continued evolution of H5 subtype viruses in nature and provide potential recombination of AIVs of different origins. In this study, we carried out surveillance of AIVs in ducks, geese and the environmen
PMID 27151540

The clinical outcome of pazopanib treatment in Japanese patients with relapsed soft tissue sarcoma: A Japanese Musculoskeletal Oncology Group (JMOG) study.

Nakamura T1, Matsumine A1, Kawai A2, Araki N3, Goto T4, Yonemoto T5, Sugiura H6,7, Nishida Y8, Hiraga H9, Honoki K10, Yasuda T11, Boku S12, Sudo A1, Ueda T13.
Cancer.Cancer.2016 May 1;122(9):1408-16. doi: 10.1002/cncr.29961. Epub 2016 Mar 11.
BACKGROUND: Because the efficacy and safety of pazopanib in Japanese patients with soft tissue sarcoma (STS) had not been evaluated previously in a large-scale cohort, the authors investigated the efficacy and safety of pazopanib in 156 Japanese patients with relapsed STS. This was a retrospective s
PMID 26970174

No clinical utility of KRAS variant rs61764370 for ovarian or breast cancer.

Ovarian Cancer Association Consortium, Breast Cancer Association Consortium, and Consortium of Modifiers of BRCA1 and BRCA2, Hollestelle A, van der Baan FH, Berchuck A, Johnatty SE, Aben KK, Agnarsson BA, Aittomäki K, Alducci E, Andrulis IL, Anton-Culver H, Antonenkova NN, Antoniou AC, Apicella C, Arndt V, Arnold N, Arun BK, Arver B, Ashworth A; Australian Ovarian Cancer Study Group, Baglietto L, Balleine R, Bandera EV, Barrowdale D, Bean YT, Beckmann L, Beckmann MW, Benitez J, Berger A, Berger R, Beuselinck B, Bisogna M, Bjorge L, Blomqvist C, Bogdanova NV, Bojesen A, Bojesen SE, Bolla MK, Bonanni B, Brand JS, Brauch H; Breast Cancer Family Register, Brenner H, Brinton L, Brooks-Wilson A, Bruinsma F, Brunet J, Brüning T, Budzilowska A, Bunker CH, Burwinkel B, Butzow R, Buys SS, Caligo MA, Campbell I, Carter J, Chang-Claude J, Chanock SJ, Claes KB, Collée JM, Cook LS, Couch FJ, Cox A, Cramer D, Cross SS, Cunningham JM, Cybulski C, Czene K, Damiola F, Dansonka-Mieszkowska A, Darabi H, de la Hoya M, deFazio A, Dennis J, Devilee P, Dicks EM, Diez O, Doherty JA, Domchek SM, Dorfling CM, Dörk T, Silva Idos S, du Bois A, Dumont M, Dunning AM, Duran M, Easton DF, Eccles D, Edwards RP, Ehrencrona H, Ejlertsen B, Ekici AB, Ellis SD; EMBRACE, Engel C, Eriksson M, Fasching PA, Feliubadalo L, Figueroa J, Flesch-Janys D, Fletcher O, Fontaine A, Fortuzzi S, Fostira F, Fridley BL, Friebel T, Friedman E, Friel G, Frost D, Garber J, García-Closas M, Gayther SA; GEMO Study Collaborators; GENICA Network, Gentry-Maharaj A, Gerdes AM, Giles GG, Glasspool R, Glendon G, Godwin AK, Goodman MT, Gore M, Greene MH, Grip M, Gronwald J, Gschwantler Kaulich D, Guénel P, Guzman SR, Haeberle L, Haiman CA, Hall P, Halverson SL, Hamann U, Hansen TV, Harter P, Hartikainen JM, Healey S; HEBON, Hein A, Heitz F, Henderson BE, Herzog J, T Hildebrandt MA, Høgdall CK, Høgdall E, Hogervorst FB, Hopper JL, Humphreys K, Huzarski T, Imyanitov EN, Isaacs C, Jakubowska A, Janavicius R, Jaworska K, Jensen A, Jensen UB, Johnson N, Jukkola-Vuorinen A, Kabisch M, Karlan BY, Kataja V, Kauff N; KConFab Investigators, Kelemen LE, Kerin MJ, Kiemeney LA, Kjaer SK, Knight JA, Knol-Bout JP, Konstantopoulou I, Kosma VM, Krakstad C, Kristensen V, Kuchenbaecker KB, Kupryjanczyk J, Laitman Y, Lambrechts D, Lambrechts S, Larson MC, Lasa A, Laurent-Puig P, Lazaro C, Le ND, Le Marchand L, Leminen A, Lester J, Levine DA, Li J, Liang D, Lindblom A, Lindor N, Lissowska J, Long J, Lu KH, Lubinski J, Lundvall L, Lurie G, Mai PL, Mannermaa A, Margolin S, Mariette F, Marme F, Martens JW, Massuger LF, Maugard C, Mazoyer S, McGuffog L, McGuire V, McLean C, McNeish I, Meindl A, Menegaux F, Menéndez P, Menkiszak J, Menon U, Mensenkamp AR, Miller N, Milne RL, Modugno F, Montagna M, Moysich KB, Müller H, Mulligan AM, Muranen TA, Narod SA, Nathanson KL, Ness RB, Neuhausen SL, Nevanlinna H, Neven P, Nielsen FC, Nielsen SF, Nordestgaard BG, Nussbaum RL, Odunsi K, Offit K, Olah E, Olopade OI, Olson JE, Olson SH, Oosterwijk JC, Orlow I, Orr N, Orsulic S, Osorio A, Ottini L, Paul J, Pearce CL, Pedersen IS, Peissel B, Pejovic T, Pelttari LM, Perkins J, Permuth-Wey J, Peterlongo P, Peto J, Phelan CM, Phillips KA, Piedmonte M, Pike MC, Platte R, Plisiecka-Halasa J, Poole EM, Poppe B, Pylkäs K, Radice P, Ramus SJ, Rebbeck TR, Reed MW, Rennert G, Risch HA, Robson M, Rodriguez GC, Romero A, Rossing MA, Rothstein JH, Rudolph A, Runnebaum I, Salani R, Salvesen HB, Sawyer EJ, Schildkraut JM, Schmidt MK, Schmutzler RK, Schneeweiss A, Schoemaker MJ, Schrauder MG, Schumacher F, Schwaab I, Scuvera G, Sellers TA, Severi G, Seynaeve CM, Shah M, Shrubsole M, Siddiqui N, Sieh W, Simard J, Singer CF, Sinilnikova OM, Smeets D, Sohn C, Soller M, Song H, Soucy P, Southey MC, Stegmaier C, Stoppa-Lyonnet D, Sucheston L; SWE-BRCA, Swerdlow A, Tangen IL, Tea MK, Teixeira MR, Terry KL, Terry MB, Thomassen M, Thompson PJ, Tihomirova L, Tischkowitz M, Toland AE, Tollenaar RA, Tomlinson I, Torres D, Truong T, Tsimiklis H, Tung N, Tworoger SS, Tyrer JP, Vachon CM, Van 't Veer LJ, van Altena AM, Van Asperen CJ, van den Berg D, van den Ouweland AM, van Doorn HC, Van Nieuwenhuysen E, van Rensburg EJ, Vergote I, Verhoef S, Vierkant RA, Vijai J, Vitonis AF, von Wachenfeldt A, Walsh C, Wang Q, Wang-Gohrke S, Wappenschmidt B, Weischer M, Weitzel JN, Weltens C, Wentzensen N, Whittemore AS, Wilkens LR, Winqvist R, Wu AH, Wu X, Yang HP, Zaffaroni D, Pilar Zamora M, Zheng W, Ziogas A, Chenevix-Trench G, Pharoah PD, Rookus MA, Hooning MJ, Goode EL.
Gynecologic oncology.Gynecol Oncol.2016 May;141(2):386-401. doi: 10.1016/j.ygyno.2015.04.034. Epub 2015 May 2.
OBJECTIVE: Clinical genetic testing is commercially available for rs61764370, an inherited variant residing in a KRAS 3' UTR microRNA binding site, based on suggested associations with increased ovarian and breast cancer risk as well as with survival time. However, prior studies, emphasizing particu
PMID 25940428